Thursday, 28 May 2009

Mesothelioma Therapy Treatment

The Mesothelioma Applied Research Foundation (MARF) notes that the preferred approach to this type of cancer involves combining surgery with either chemotherapy or radiation mesothelioma therapy treatment. Radiation treatments may also be used as the main treatment for patients whose health is too poor to undergo surgery.

Radiation mesothelioma therapy treatment uses high-energy x-rays to kill cancer cells. There are two types of radiation treatment: external beam radiation therapy and brachytherapy.

External beam radiation therapy uses radiation from outside the body that is focused on the cancer. This is the preferred type of radiation mesothelioma therapy treatment according to the American Cancer Society (ACS). Patients undergo these treatments five days a week for three-five weeks.

The ACS says that brachytherapy places radioactive material directly into the chest or abdomen at the site of the mesothelioma, but this is rarely used.

Like chemotherapy, radiation mesothelioma therapy treatments can be used in addition to surgery to destroy small deposits of cancer that cannot be seen and removed during surgery. Radiation therapy can also be used simply to relieve symptoms like shortness of breath, pain, bleeding, and difficulty swallowing.

After the removal of fluid buildup, radiation mesothelioma therapy treatments placed directly into the chest may help prevent fluid from coming back. Doctors also may use radiation to prevent the occurrence of mesothelioma in the area of surgical incisions.

Also like chemotherapy, radiation mesothelioma therapy treatments can produce side effects. These may include:

Fatigue
Mild skin irritations resembling sunburn
Possible lung damage leading to difficulty breathing
Nausea, vomiting, and diarrhea

Gene Ratio Test Predicts Survival Rates in Mesothelioma Patients

Researchers at the International Mesothelioma Program (IMP) have recently finished a study to determine the effectiveness of a gene ratio test in predicting which mesothelioma patients had the best prognosis for survival following surgery. This research supplemented previous research that compared the differences in gene expression in tissue samples of malignant pleural mesothelioma stratified by patient outcome after surgical therapy and developed a gene ratio test that was calculated from the expression levels of four genes to predict patient outcome.

The researchers prospectively examined three ratios of gene expression in 120 consecutive patients with malignant pleural mesothelioma. The patients underwent surgery at Brigham and Women’s hospital in Boston, Massachusetts. The researchers collected gene expression data for four different genes and determined three gene expression ratios. The researchers stratified the patients into a good outcome group (58%) and a poor outcome group (42%) based on the results of the gene expression test.

Doctors found that the gene ratio test, combined with other diagnostic tools, allowed them to distinguish between patients at high risk and patients at low risk. Moreover, this allowed them to more accurately determine expected survival after surgery. Participation in the study was limited to patients who were willing and able to undergo an invasive and aggressive surgical treatment. Due to this the results may not apply to those who are not candidates for surgery because of age or current health level.

Former Navy Worker Wins Over $12 Million in Mesothelioma Lawsuit

A former Navy machinist, who developed mesothelioma after years of asbestos exposure, has won over $12 million dollars in damages. Charles H. Cundiff, 66, handled insulating cement while working on the USS Kitty Hawk during his years of military service from 1962 to 1966. Many years later, Cundiff was diagnosed with mesothelioma due to asbestos exposure from the insulating cement.

Cundiff filed a lawsuit against John Crane, Inc., which made Insulag, and Lone Star Industries, which delivered the asbestos-laced insulating cement to Puget Sound Naval Shipyard. During the overhaul of the vessel at the shipyard, Cundiff cleaned, repaired and replaced valves, gaskets, pumps and packing’s and used Insulag cement in two engine rooms.

A Los Angeles County jury ruled on Monday that these two companies made a defective product and failed to warn Cundiff of its health hazard. For this they determined that John Crane, Inc. and Lone Star Industries must pay Cundiff $10 million for pain and suffering and $506,000 in economic damages for lost wages because he is now afflicted with mesothelioma. Additionally, his wife was awarded $1.5 million for loss of consortium.

Chemical in Cancer Tumors Linked to Depression

Receiving the news of a cancer diagnosis is something that no one wants to here. Moreover, it has been well documented that a cancer diagnosis can sometimes lead to depression in patients. However, according to research published in the Proceedings of the National Academy of Sciences (PNAS) journal, researchers found that the tumors themselves can also affect the chemical make-up of the brain and potentially cause depression.

Tests have shown that animals with tumors had increased levels of chemicals called cytokines in their blood and in the brain. Cytokines are chemicals that are produced by immune systems and have been linked to depression. Researchers tested rats bred to have cancer and found that they were less likely to try to escape when forced to swim through water or to eat a treat of sugar water, typical signs of depression.

"Rats are commonly used to test drugs that are being studied for potential human benefits, such as treating depression," said Brian Prendergast, from the University of Chicago, who led the study. "In this case, examining behavioral responses to tumors in non-human animals is particularly useful because the rats have no awareness of the disease, and thus their behavioral changes were likely the result of purely biological factors."

Asbestos More Damaging Than Originally Thought

Experts are now reporting that asbestos can cause ovarian cancer and cancer of the larynx. A group of 27 World Health Organization scientists have listed these findings in the Lancet Oncology Medical Journal.
The scientists have also reported that there is limited evidence that asbestos fibers can raise the risk bowel, stomach, or throat cancer.
It is already known that asbestos causes mesothelioma.
Based on all of these findings English doctors, charities, unions, and MPs are calling for the English government to create a 10 million pound center for asbestos related disease.